Mateos, M., Bringhen, S., Richardson, P. G., Lahuerta, J. J., Larocca, A., Oriol, A., . . . Palumbo, A. (2014). Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. Ferrata Storti Foundation.
Citação norma ChicagoMateos, María-Victoria, et al. Bortezomib Cumulative Dose, Efficacy, and Tolerability With Three Different Bortezomib-melphalan-prednisone Regimens in Previously Untreated Myeloma Patients Ineligible for High-dose Therapy. Ferrata Storti Foundation, 2014.
Citação norma MLAMateos, María-Victoria, et al. Bortezomib Cumulative Dose, Efficacy, and Tolerability With Three Different Bortezomib-melphalan-prednisone Regimens in Previously Untreated Myeloma Patients Ineligible for High-dose Therapy. Ferrata Storti Foundation, 2014.